2013 Q4 Form 10-Q Financial Statement

#000119312513421347 Filed on November 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $232.5M $224.7M $190.9M
YoY Change 23.34% 17.74% 23.11%
Cost Of Revenue $132.2M $132.1M $121.8M
YoY Change 15.53% 8.46% 26.26%
Gross Profit $100.2M $92.59M $69.04M
YoY Change 35.42% 34.12% 17.92%
Gross Profit Margin 43.11% 41.2% 36.17%
Selling, General & Admin $26.10M $29.83M $20.76M
YoY Change 10.59% 43.66% 13.63%
% of Gross Profit 26.04% 32.22% 30.08%
Research & Development $11.00M $10.80M $9.600M
YoY Change 25.0% 12.5% 12.94%
% of Gross Profit 10.98% 11.66% 13.91%
Depreciation & Amortization $7.600M $7.300M $7.000M
YoY Change 11.76% 4.29% 9.37%
% of Gross Profit 7.58% 7.88% 10.14%
Operating Expenses $37.10M $29.83M $20.76M
YoY Change 14.51% 43.66% 13.63%
Operating Profit $63.17M $51.99M $38.72M
YoY Change 51.89% 34.25% 21.86%
Interest Expense $100.0K $4.000K $7.000K
YoY Change 0.0% -42.86% -53.33%
% of Operating Profit 0.16% 0.01% 0.02%
Other Income/Expense, Net
YoY Change
Pretax Income $63.30M $52.18M $38.86M
YoY Change 51.8% 34.27% 22.04%
Income Tax $16.20M $12.19M $9.207M
% Of Pretax Income 25.59% 23.36% 23.69%
Net Earnings $47.06M $40.00M $29.66M
YoY Change 52.05% 34.86% 27.49%
Net Earnings / Revenue 20.25% 17.8% 15.54%
Basic Earnings Per Share $1.16 $0.98 $0.73
Diluted Earnings Per Share $1.15 $0.98 $0.73
COMMON SHARES
Basic Shares Outstanding 40.69M shares 40.68M shares 40.42M shares
Diluted Shares Outstanding 40.91M shares 40.59M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $384.4M $380.9M $263.4M
YoY Change 49.46% 44.61% 3.05%
Cash & Equivalents $384.4M $380.9M $263.4M
Short-Term Investments
Other Short-Term Assets $28.55M $14.22M $13.37M
YoY Change 58.93% 6.42% -65.9%
Inventory $368.4M $369.7M $350.1M
Prepaid Expenses
Receivables $279.3M $243.3M $240.8M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.081B $1.035B $891.9M
YoY Change 16.94% 16.06% 18.92%
LONG-TERM ASSETS
Property, Plant & Equipment $304.8M $300.9M $293.1M
YoY Change 2.98% 2.68% 8.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.99M $11.17M $11.22M
YoY Change -0.76% -0.47% -7.26%
Total Long-Term Assets $315.8M $312.1M $304.3M
YoY Change -2.93% 2.56% 7.72%
TOTAL ASSETS
Total Short-Term Assets $1.081B $1.035B $891.9M
Total Long-Term Assets $315.8M $312.1M $304.3M
Total Assets $1.397B $1.347B $1.196B
YoY Change 11.77% 12.63% 15.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.45M $36.12M $36.30M
YoY Change 60.6% -0.49% 15.23%
Accrued Expenses $38.90M $39.90M $39.40M
YoY Change 11.46% 1.27% 18.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $149.4M $138.9M $155.2M
YoY Change -3.64% -10.5% 17.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $149.4M $138.9M $155.2M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $154.8M $148.7M $164.7M
YoY Change -6.2% -9.77% 16.92%
SHAREHOLDERS EQUITY
Retained Earnings $1.070B $1.023B $869.0M
YoY Change 18.87% 17.69%
Common Stock $192.4M $197.6M $177.5M
YoY Change 6.71% 11.36%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.00M
YoY Change
Treasury Stock Shares
Shareholders Equity $1.242B $1.199B $1.031B
YoY Change
Total Liabilities & Shareholders Equity $1.397B $1.347B $1.196B
YoY Change 13.43% 12.63% 15.86%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $47.06M $40.00M $29.66M
YoY Change 52.05% 34.86% 27.49%
Depreciation, Depletion And Amortization $7.600M $7.300M $7.000M
YoY Change 11.76% 4.29% 9.37%
Cash From Operating Activities $21.30M $54.80M $22.50M
YoY Change 1083.33% 143.56% 42.41%
INVESTING ACTIVITIES
Capital Expenditures -$12.60M -$6.900M -$12.90M
YoY Change 23.53% -46.51% 4.88%
Acquisitions
YoY Change
Other Investing Activities $600.0K -$100.0K $200.0K
YoY Change 20.0% -150.0% -33.33%
Cash From Investing Activities -$12.10M -$7.000M -$12.70M
YoY Change 24.74% -44.88% 4.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.900M 1.900M 3.100M
YoY Change -890.0% -38.71%
NET CHANGE
Cash From Operating Activities 21.30M 54.80M 22.50M
Cash From Investing Activities -12.10M -7.000M -12.70M
Cash From Financing Activities -7.900M 1.900M 3.100M
Net Change In Cash 1.300M 49.70M 12.90M
YoY Change -118.84% 285.27% 248.65%
FREE CASH FLOW
Cash From Operating Activities $21.30M $54.80M $22.50M
Capital Expenditures -$12.60M -$6.900M -$12.90M
Free Cash Flow $33.90M $61.70M $35.40M
YoY Change 182.5% 74.29% 25.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40432000 shares
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
263421000
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40691202 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40691202 shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
114790000
CY2013Q3 us-gaap Unbilled Receivables Not Billable At Balance Sheet Date Amount Expected To Be Collected Within One Year
UnbilledReceivablesNotBillableAtBalanceSheetDateAmountExpectedToBeCollectedWithinOneYear
55600000
CY2013Q3 us-gaap Assets
Assets
1347256000
CY2013Q3 us-gaap Noncurrent Assets
NoncurrentAssets
312090000
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19138000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
36122000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
138924000
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20730000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-21770000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
1198602000
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
197212000
CY2013Q3 us-gaap Billings In Excess Of Cost
BillingsInExcessOfCost
50622000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1022753000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
407000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1347256000
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9730000
CY2013Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
31779000
CY2013Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
12312000
CY2013Q3 us-gaap Liabilities
Liabilities
148654000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Assets Current
AssetsCurrent
1035166000
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11168000
CY2013Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
82053000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
380942000
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
243293000
CY2013Q3 us-gaap Inventory Net
InventoryNet
369658000
CY2013Q3 us-gaap Inventory Gross
InventoryGross
401437000
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
14224000
CY2013Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
27049000
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
204594000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
300922000
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40693202 shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
298576000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40475061 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40475061 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20250000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
28302000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
155089000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14620000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-13830000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
1066432000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
179868000
CY2012Q4 us-gaap Billings In Excess Of Cost
BillingsInExcessOfCost
86313000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
899989000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
405000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1231447000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9926000
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
30426000
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5604000
CY2012Q4 us-gaap Liabilities
Liabilities
165015000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Assets Current
AssetsCurrent
924388000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11077000
CY2012Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
86007000
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
97379000
CY2012Q4 us-gaap Unbilled Receivables Not Billable At Balance Sheet Date Amount Expected To Be Collected Within One Year
UnbilledReceivablesNotBillableAtBalanceSheetDateAmountExpectedToBeCollectedWithinOneYear
62100000
CY2012Q4 us-gaap Assets
Assets
1231447000
CY2012Q4 us-gaap Noncurrent Assets
NoncurrentAssets
307059000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
257191000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
263213000
CY2012Q4 us-gaap Inventory Net
InventoryNet
362181000
CY2012Q4 us-gaap Inventory Gross
InventoryGross
392607000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17965000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
23838000
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
209221000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
295982000
dei Trading Symbol
TradingSymbol
DRQ
dei Entity Registrant Name
EntityRegistrantName
DRIL-QUIP INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001042893
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
-74000 shares
us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 2%; FONT-SIZE: 10pt"> <i>Revenue Recognition</i></p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <i>Product Revenue</i></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company earns product revenues from two methods:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">product revenues recognized under the percentage-of-completion method; and</td> </tr> </table> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">product revenues from the sale of products that do not qualify for the percentage-of-completion method.</td> </tr> </table> </div>
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.01
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40821000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
204000 shares
us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 2%; FONT-SIZE: 10pt"> <i>Service revenue</i></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company earns service revenues from three sources:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">technical advisory assistance;</td> </tr> </table> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">rental of running tools; and</td> </tr> </table> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">rework and reconditioning of customer-owned Dril-Quip products.</td> </tr> </table> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company does not install products for its customers, but it provides technical advisory assistance. At the time of delivery of the product, the customer is not obligated to buy or rent the Company&#x2019;s running tools and the Company is not obligated to perform any subsequent services relating to installation. Technical advisory assistance service revenue is recorded at the time the service is rendered. Service revenues associated with the rental of running and installation tools are recorded as earned. Rework and reconditioning service revenues are recorded when the refurbishment process is complete.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company normally negotiates contracts for products, including those accounted for under the percentage-of-completion method, and services separately. For all product sales, it is the customer&#x2019;s decision as to the timing of the product installation as well as whether Dril-Quip running tools will be purchased or rented. Furthermore, the customer is under no obligation to utilize the Company&#x2019;s technical advisory services. The customer may use a third party or their own personnel</p> </div>
us-gaap Revenue Recognition Percentage Of Completion Method
RevenueRecognitionPercentageOfCompletionMethod
<div> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 2%; FONT-SIZE: 10pt"> <i>Revenues recognized under the percentage-of-completion method</i></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company uses the percentage-of-completion method on long-term project contracts that have the following characteristics:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The contracts call for products which are designed to customer specifications;</td> </tr> </table> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The structural designs are unique and require significant engineering and manufacturing efforts generally requiring more than one year in duration;</td> </tr> </table> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The contracts contain specific terms as to milestones, progress billings and delivery dates; and</td> </tr> </table> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Product requirements cannot be filled directly from the Company&#x2019;s standard inventory.</td> </tr> </table> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> For each project, the Company prepares a detailed analysis of estimated costs, profit margin, completion date and risk factors which include availability of material, production efficiencies and other factors that may impact the project. On a quarterly basis, management reviews the progress of each project, which may result in revisions of previous estimates, including revenue recognition. The Company calculates the percent complete and applies this percentage to determine the revenues earned and the appropriate portion of total estimated costs. Losses, if any, are recorded in full in the period they become known. Historically, the Company&#x2019;s estimates of total costs and costs to complete have approximated actual costs incurred to complete the project.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Under the percentage-of-completion method, billings may not correlate directly to the revenue recognized. Based upon the terms of the specific contract, billings may be in excess of the revenue recognized, in which case the amounts are included in customer prepayments as a liability on the Condensed Consolidated Balance Sheets. Likewise, revenue recognized may exceed customer billings in which case the amounts are reported in trade receivables. Unbilled revenues are expected to be billed and collected within one year. As of September&#xA0;30, 2013 and December&#xA0;31, 2012, receivables included $55.6 million and $62.1 million of unbilled receivables, respectively. For the quarter ended September&#xA0;30, 2013, there were 12 projects representing approximately 15% of the Company&#x2019;s total revenue and approximately 18% of its product revenues that were accounted for using percentage-of-completion accounting, compared to 17 projects during the third quarter of 2012 which represented 21% of the Company&#x2019;s total revenues and 25% of its product revenues. For the nine months ended September&#xA0;30, 2013, there were 16 projects representing 13% of the Company&#x2019;s total revenues and 15% of its product revenues, compared to 19 projects representing 19% of the Company&#x2019;s total revenues and 22% of its product revenues for the nine months ended September&#xA0;30, 2012, all of which were accounted for using percentage-of-completion accounting.</p> </div>
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.02
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
140854000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40617000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"> <i>Use of Estimates</i></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Some of the Company&#x2019;s more significant estimates are those affected by critical accounting policies for revenue recognition, inventories and contingent liabilities as discussed more fully in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#xA0;31, 2012.</p> </div>
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12075000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
114824000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30037000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12911000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
228000
us-gaap Costs And Expenses
CostsAndExpenses
479533000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11255000
us-gaap Cost Of Services
CostOfServices
58493000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
323169000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3443000
us-gaap Revenues
Revenues
639910000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-122000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
536781000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2586000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1893000
us-gaap Interest Income Other
InterestIncomeOther
486000
us-gaap Operating Income Loss
OperatingIncomeLoss
160377000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
103129000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
160839000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7940000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-17730000
us-gaap Net Income Loss
NetIncomeLoss
122764000
us-gaap Share Based Compensation
ShareBasedCompensation
6257000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
123751000
us-gaap Interest Expense
InterestExpense
24000
us-gaap Cost Of Revenue
CostOfRevenue
381662000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29809000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9362000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21717000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1893000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68732000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38075000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1451000
drq Engineering And Product Development
EngineeringAndProductDevelopment
29139000
drq Number Of Projects
NumberOfProjects
16 Project
drq Number Of Geographic Segments
NumberOfGeographicSegments
3 Segment
drq Reporting Information Eliminations
ReportingInformationEliminations
38601000
drq Percentage Of Product Revenue
PercentageOfProductRevenue
0.15 pure
drq Allocated Share Based Compensation Expense Capitalized
AllocatedShareBasedCompensationExpenseCapitalized
0
drq Percentage Of Cumulative Revenue
PercentageOfCumulativeRevenue
0.13 pure
drq Revenue From Inter Company Transactions
RevenueFromInterCompanyTransactions
38601000
us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
-140000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.18
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40492000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
200000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.19
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9950000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40292000 shares
us-gaap Revenues
Revenues
544554000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-240000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
455846000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5409000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1219000
us-gaap Interest Income Other
InterestIncomeOther
329000
us-gaap Operating Income Loss
OperatingIncomeLoss
120104000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
88708000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
120412000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3412000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
59487000
us-gaap Net Income Loss
NetIncomeLoss
88257000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
70211000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
91669000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40606000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4188000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
1303000
us-gaap Costs And Expenses
CostsAndExpenses
424450000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11259000
us-gaap Cost Of Services
CostOfServices
49629000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
287567000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-459000
us-gaap Share Based Compensation
ShareBasedCompensation
3922000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-35155000
us-gaap Interest Expense
InterestExpense
21000
us-gaap Cost Of Revenue
CostOfRevenue
337196000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39303000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10040000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19410000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1219000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
58614000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32155000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2839000
drq Engineering And Product Development
EngineeringAndProductDevelopment
28640000
drq Number Of Projects
NumberOfProjects
19 Project
drq Reporting Information Eliminations
ReportingInformationEliminations
60205000
drq Percentage Of Product Revenue
PercentageOfProductRevenue
0.22 pure
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9207000
CY2012Q3 drq Engineering And Product Development
EngineeringAndProductDevelopment
9552000
drq Allocated Share Based Compensation Expense Capitalized
AllocatedShareBasedCompensationExpenseCapitalized
0
drq Percentage Of Cumulative Revenue
PercentageOfCumulativeRevenue
0.19 pure
drq Revenue From Inter Company Transactions
RevenueFromInterCompanyTransactions
60205000
CY2012Q3 us-gaap Cost Of Services
CostOfServices
18207000
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
103614000
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1300000
CY2012Q3 us-gaap Interest Expense
InterestExpense
7000
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
121821000
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20764000
CY2012Q3 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
-9000 shares
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40589000 shares
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
166000 shares
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40423000 shares
CY2012Q3 us-gaap Revenues
Revenues
190860000
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
159465000
CY2012Q3 us-gaap Interest Income Other
InterestIncomeOther
148000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
38723000
CY2012Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
31395000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
38864000
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7105000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
29657000
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
36762000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
152137000
CY2012Q3 drq Number Of Projects
NumberOfProjects
17 Project
CY2012Q3 drq Reporting Information Eliminations
ReportingInformationEliminations
18420000
CY2012Q3 drq Percentage Of Product Revenue
PercentageOfProductRevenue
0.25 pure
CY2012Q3 drq Allocated Share Based Compensation Expense Capitalized
AllocatedShareBasedCompensationExpenseCapitalized
0
CY2012Q3 drq Percentage Of Cumulative Revenue
PercentageOfCumulativeRevenue
0.21 pure
CY2012Q3 drq Revenue From Inter Company Transactions
RevenueFromInterCompanyTransactions
18420000
CY2013Q3 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
-8000 shares
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.98
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40911000 shares
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
228000 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40683000 shares
CY2013Q3 us-gaap Revenues
Revenues
224724000
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
187437000
CY2013Q3 us-gaap Interest Income Other
InterestIncomeOther
203000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
51985000
CY2013Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
37287000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
52184000
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16194000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
39995000
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
56189000
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
172739000
CY2013Q3 us-gaap Cost Of Services
CostOfServices
18947000
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
113184000
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2100000
CY2013Q3 us-gaap Interest Expense
InterestExpense
4000
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
132131000
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29830000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12189000
CY2013Q3 drq Engineering And Product Development
EngineeringAndProductDevelopment
10778000
CY2013Q3 drq Number Of Projects
NumberOfProjects
12 Project
CY2013Q3 drq Reporting Information Eliminations
ReportingInformationEliminations
10295000
CY2013Q3 drq Percentage Of Product Revenue
PercentageOfProductRevenue
0.18 pure
CY2013Q3 drq Allocated Share Based Compensation Expense Capitalized
AllocatedShareBasedCompensationExpenseCapitalized
0
CY2013Q3 drq Percentage Of Cumulative Revenue
PercentageOfCumulativeRevenue
0.15 pure
CY2013Q3 drq Revenue From Inter Company Transactions
RevenueFromInterCompanyTransactions
10295000

Files In Submission

Name View Source Status
0001193125-13-421347-index-headers.html Edgar Link pending
0001193125-13-421347-index.html Edgar Link pending
0001193125-13-421347.txt Edgar Link pending
0001193125-13-421347-xbrl.zip Edgar Link pending
d600352d10q.htm Edgar Link pending
d600352dex311.htm Edgar Link pending
d600352dex312.htm Edgar Link pending
d600352dex321.htm Edgar Link pending
d600352dex322.htm Edgar Link pending
drq-20130930.xml Edgar Link completed
drq-20130930.xsd Edgar Link pending
drq-20130930_cal.xml Edgar Link unprocessable
drq-20130930_def.xml Edgar Link unprocessable
drq-20130930_lab.xml Edgar Link unprocessable
drq-20130930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending